Loading provider…
Loading provider…
Hematology & Oncology Physician in La Crosse, WI
NPI: 1104265339Primary Practice Location
GUNDERSEN LUTHERAN MEDICAL CENTER
1900 South Ave, La Crosse, WI
Primary Employer
Gundersen Lutheran Onalaska Clinic
gundersenhealth.org
HQ Phone
Get MD Gil's Phone Numberphone_androidMobile
Get MD Gil's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWI State Medical License

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 95 | 142 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 92 | 213 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 33 | 33 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 29 | 37 |
| 5 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 15 | 25 |
Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction.
Authors: Jeffrey Gershenwald, Cynthia Thomson
Publication Date: 2018-09-21
Authors: Dahl, Matías J, Lofgren, Kristopher A, Haugen, Cleo, Harmon, Gil E, Hughes, Sarah P, Cowden Dahl, Karen D
Journal: Front Oncol
Publication Date: 2024-03-13
Imaging Pandora's Box: incidental findings in elderly patients evaluated for transcatheter aortic valve replacement.
Authors: Kevin Greason, Paul Sorajja, Nancy Nielsen, Eric Williamson, Vuyisile Nkomo, Rakesh Suri
Publication Date: 2013-12-26
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Topotecan Hydrochloride, DRUG: Olaparib, DRUG: Paclitaxel, PROCEDURE: Computed Tomography with Contrast, PROCEDURE: Computed Tomography, BIOLOGICAL: Durvalumab, PROCEDURE: Multigated Acquisition Scan, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride, PROCEDURE: Echocardiography Test, DRUG: Cediranib Maleate
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, PROCEDURE: Biospecimen Collection, DRUG: Olaparib, PROCEDURE: Computed Tomography, BIOLOGICAL: Durvalumab, PROCEDURE: Multigated Acquisition Scan, PROCEDURE: Echocardiography, PROCEDURE: Bone Marrow Aspirate, DRUG: Capivasertib, DRUG: Cediranib Maleate
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, RADIATION: External Beam Radiation Therapy, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, RADIATION: Brachytherapy